Microport Cardioflow Medtech Corp
HKEX:2160
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Microport Cardioflow Medtech Corp
Other Equity
Microport Cardioflow Medtech Corp
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Microport Cardioflow Medtech Corp
HKEX:2160
|
Other Equity
¥328.5m
|
CAGR 3-Years
105%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Other Equity
¥63.8k
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Other Equity
¥133.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
80%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Other Equity
¥303.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Andon Health Co Ltd
SZSE:002432
|
Other Equity
¥1.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
129%
|
CAGR 10-Years
166%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Other Equity
-¥14.3m
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Microport Cardioflow Medtech Corp
Glance View
MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.
See Also
What is Microport Cardioflow Medtech Corp's Other Equity?
Other Equity
328.5m
CNY
Based on the financial report for Dec 31, 2025, Microport Cardioflow Medtech Corp's Other Equity amounts to 328.5m CNY.
What is Microport Cardioflow Medtech Corp's Other Equity growth rate?
Other Equity CAGR 5Y
32%
Over the last year, the Other Equity growth was 0%. The average annual Other Equity growth rates for Microport Cardioflow Medtech Corp have been 105% over the past three years , 32% over the past five years .
